Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,838,977
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
4,298,835
-
Shares change
-
+17,606
-
Total reported value, excl. options
-
$27,271,000
-
Value change
-
+$1,162,755
-
Number of buys
-
11
-
Number of sells
-
2
-
Price
-
$6.34
Institutional Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2018
As of 30 Jun 2018 CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,298,835 shares of stock of the company.
Largest 10 holders included Battery Partners IX, LLC, NEA Management Company, LLC, VANGUARD GROUP INC, Granite Investment Partners, LLC, TOCQUEVILLE ASSET MANAGEMENT L.P., PERKINS CAPITAL MANAGEMENT INC, ESSEX INVESTMENT MANAGEMENT CO LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and BlackRock Inc..
This table shows 18 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.